Transgender hormone therapy (male-to-female) medical professional. Inducers of CYP3A4 and other cytochrome P450 enzymes can reduce the effects of MTF HRT. A variety of different sex-hormonal medications are used in feminizing hormone therapy for transgender women. These include estrogens to induce feminization and suppress testosterone levels; antiandrogens such as androgen receptor antagonists, antigonadotropins, GnRH modulators, and 5α-reductase inhibitors to further oppose the effects of androgens like testosterone; and progestogens for various possible though uncertain benefits. Estrogens are the major sex hormones in women, and are responsible for the development and maintenance of feminine secondary sexual characteristics, such as breasts, wide hips, and a feminine
Sexual conflict selection, continuous sexual conflict creates an environment in which mating frequency and male secondary sexual trait development are somewhat in step with the female's degree of resistance. It has primarily been studied in animals, though it can in principle apply to any sexually reproducing organism, such as plants and fungi. There is some evidence for sexual conflict in plants. Sexual conflict takes two major forms: Sexual conflict may lead to antagonistic co-evolution, in which one sex (usually male) evolves a favorable trait that is offset by a countering trait in the other sex. Similarly, interlocus sexual conflict can be the